Document Detail

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure.
MedLine Citation:
PMID:  12864774     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Progression of heart failure is associated with interstitial changes in the heart and in areas distant from the heart. Enhanced expression of metalloproteinases 2 and 9 and of metalloproteinases tissue inhibitors 1 and 2 have been found in ventricular tissue of patients with heart failure. Our aim was to determine whether increased activity of metalloproteinase-2, metalloproteinase-9 and of metalloproteinases tissue inhibitor-1 and metalloproteinases tissue inhibitor-2 were also present in plasma of patients with heart failure. DESIGN: Levels of metalloproteinase-2, metalloproteinase-9 and of metalloproteinase tissue inhibitor-1 and metalloproteinases tissue inhibitor-2 were measured in venous blood of 51 patients with heart failure, and were compared with levels of 52 control subjects. Samples collected from patients and control subjects were assayed for gelatinolytic activity (zymography) and for protein levels. RESULTS: Compared with the control subjects, the patients with heart failure had a significant increase in activity levels (mean +/- SE, ng mL(-1)) of prometalloproteinase-9 (95.1+/-11.2 and 38.9+/-4.5*), activ. metalloproteinase-9 (18.4+/-2.5 and 10.9+/-1.3*), and of prometalloproteinase-2 (571.4+/-26.1 and 456.8+/-21.1*) (respectively: patients and control subjects; *P<0.05). Metalloproteinases tissue inhibitor-1, but not metalloproteinases tissue inhibitor-2 protein values were higher in the patients. Among the patients, clinical status and New York Heart Association (NYHA) class did not correlate with the metalloproteinase concentrations. Positive correlations with left ventricular volumes, and negative correlations with lipid values were obtained for prometalloproteinase-2; positive correlations with total number of white cells and neutrophils were obtained for prometalloproteinase-9; and positive correlations with lactate dehydrogenase, serum fibrinogen, aspartate transaminases were found for activ. metalloproteinase-9. CONCLUSIONS: Regardless of the clinical phase of heart failure, elevated levels of activity and of circulating metalloproteinase protein levels suggest the presence of persistent extracellular remodeling in patients with heart failure.
P Altieri; C Brunelli; S Garibaldi; A Nicolino; S Ubaldi; P Spallarossa; L Olivotti; P Rossettin; A Barsotti; G Ghigliotti
Related Documents :
17170594 - Illness representation of patients with systolic heart failure.
8058694 - Aging and heart failure.
4044234 - High-output cardiac failure as a presenting symptom of plasma cell leukemia.
8895724 - Survival after trauma pneumonectomy: the pathophysiologic balance of shock resuscitatio...
24005254 - Invited review eb 2012: peripheral cardiac sympathetic hyperactivity in cardiovascular ...
3698304 - Isoforms of creatine kinase mm and mb in acute myocardial infarction: a clinical evalua...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of clinical investigation     Volume:  33     ISSN:  0014-2972     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2003 Aug 
Date Detail:
Created Date:  2003-07-16     Completed Date:  2003-09-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  648-56     Citation Subset:  IM    
Department of Internal Medicine, University of Genova, Genova, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiac Output, Low / blood*
Enzyme-Linked Immunosorbent Assay / methods
Extracellular Matrix / metabolism
Matrix Metalloproteinase 2 / blood*
Matrix Metalloproteinase 9 / blood*
Middle Aged
Protease Inhibitors / blood
Tissue Inhibitor of Metalloproteinase-1 / blood
Tissue Inhibitor of Metalloproteinase-2 / blood
Tissue Inhibitor of Metalloproteinases / blood
Reg. No./Substance:
0/Protease Inhibitors; 0/Tissue Inhibitor of Metalloproteinase-1; 0/Tissue Inhibitor of Metalloproteinases; 127497-59-0/Tissue Inhibitor of Metalloproteinase-2; EC Metalloproteinase 2; EC Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  ACE DD genotype: an independent predisposition factor to venous thromboembolism.
Next Document:  Do temporal arteritis lesions contain bacterial DNA?